Earnings History Data for Madrigal Pharmaceuticals, Inc. (MDGL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28-02-2024 | PM | MDGL | Madrigal Pharmaceuticals | 4,592 | -5.68 | -5.32 | 0.00 | Madrigal Pharmaceuticals GAAP EPS of -$5.68 misses by $0.42 [2/28/2024 7:24 AM] |
253.95 | 14.15 (5.90%) |
0.0 | 0.0 (0.00%) |
119.76 - 322.67 | 417,688 | 520,000 | 0 | ||
| 06-11-2023 | PM | MDGL | Madrigal Pharmaceuticals | 2,538 | -5.34 | -4.78 | 0.00 | 147.40 | 0.51 (0.35%) |
0.0 | 0.0 (0.00%) |
57.21 - 322.67 | 327,436 | 410,000 | 0 | |||
|
|
||||||||||||||||||
| 08-08-2023 | PM | MDGL | Madrigal Pharmaceuticals | 3,557 | -4.69 | -4.47 | 0.00 | Madrigal Pharmaceuticals GAAP EPS of -$4.69 [8/8/2023 9:00 AM] |
169.01 | -10.48 (-5.84%) |
175.01 | -4.48 (-2.50%) |
57.21 - 322.67 | 873,604 | 240,000 | 5,328 | ||
| 09-05-2022 | PM | 8:00 AM ET (May 9) |
MDGL | Madrigal Pharmaceuticals, Inc. | 1,140 | -3.36 | -3.75 | -3.32 | Madrigal Pharmaceuticals GAAP EPS of -$3.36 beats by $0.20 [5/9/2022 6:32 AM] |
57.55 | -7.04 (-10.90%) |
64.59 | 0.0 (0.00%) |
52.33 - 137.78 | 416,356 | 220,000 | 21,884 | |
|
||||||||||||||||||
| 06-05-2021 | PM | MDGL | Madrigal Pharmaceuticals, Inc. | 2,150 | -3.32 | -3.78 | -2.34 | Madrigal Pharmaceuticals EPS beats by $0.44 [5/6/2021 6:58 AM] |
126.71 | -2.85 (-2.20%) |
126.71 | 0.0 (0.00%) |
85.52 - 142.62 | 146,670 | 90,000 | 521 | ||
| 25-02-2021 | PM | MDGL | Madrigal Pharmaceuticals, Inc. | 1,840 | -3.82 | -3.82 | -1.80 | Madrigal Pharmaceuticals EPS beats by $0.16 [2/25/2021 6:53 AM] |
122.80 | 2.61 (2.17%) |
122.80 | 0.0 (0.00%) |
56.82 - 137.28 | 140,195 | 164,622 | 5,732 | ||
| 05-11-2020 | PM | MDGL | Madrigal Pharmaceuticals, Inc. | 1,970 | -3.75 | -3.35 | -1.39 | Madrigal Pharmaceuticals EPS misses by $0.40 [11/5/2020 7:39 AM] |
132.99 | 4.99 (3.90%) |
132.99 | 0.0 (0.00%) |
56.82 - 137.28 | 205,137 | 98,992 | 3,326 | ||
|
|
||||||||||||||||||
| 06-08-2020 | PM | MDGL | Madrigal Pharmaceuticals, Inc. | 1,580 | -3.18 | -2.42 | -1.28 | Madrigal Pharmaceuticals EPS misses by $0.74 [8/6/2020 7:52 AM] |
101.49 | -4.93 (-4.63%) |
106.42 | 0.0 (0.00%) |
56.82 - 127.25 | 59,071 | 81,348 | 1,711 | ||
|
|
||||||||||||||||||